Serious adverse events · children with sickle cell anaemia and microalbuminuria
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality due to any cause · children with sickle cell anaemia and microalbuminuria
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · children with sickle cell anaemia and microalbuminuria
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Reduction or prevention of kidney disease progression · people with sickle cell disease
1 finding from 1 review
Serious adverse events · people with sickle cell disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · people with sickle cell disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · people with sickle cell disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Reduction or prevention of kidney disease progression · children with sickle cell anaemia and microalbuminuria
1 finding from 1 review
Migraine frequency Number of attacks · primary Raynaud's phenomenon
1 finding from 1 review
Severity of attacks · primary Raynaud's phenomenon
1 finding from 1 review
Duration of attacks · primary Raynaud's phenomenon
1 finding from 1 review
QoL · primary Raynaud's phenomenon
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (4 to 6‐week · primary Raynaud's phenomenon
Angiotensin‐converting enzyme inhibitors showed no clear difference in adverse events (4 to 6‐week compared with placebo (low certainty).
1 finding from 1 review
RCS · primary Raynaud's phenomenon
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Addiction Severity Index alcohol score · concurrent problem alcohol and illicit drug users
3 findings from 1 review
no estimate extracted
1 study · 163 participants
Low
no estimate extracted
1 study · 163 participants
Low
no estimate extracted
1 study · 163 participants
Low
Retention [ · concurrent problem alcohol and illicit drug users
Motivational interviewing intensive (MII) may leads to higher retention ‐ end of treatment compared with motivational interviewing (MI) to reduce alcohol consumption (low certainty).
1 finding from 1 review
Marijuana use · summary findings of female review
Intensive discharge planning and case management showed no clear difference in marijuana use compared with prison only (moderate certainty).
1 finding from 1 review
Hard drug use · summary findings of female review
Intensive discharge planning and case management showed no clear difference in hard drug use compared with prison only (moderate certainty).
1 finding from 1 review
Positive hair test for crack cocaine · summary findings of female review
Intensive discharge planning and case management showed no clear difference in positive hair test for crack cocaine compared with prison only (moderate certainty).
1 finding from 1 review
Positive hair test for marijuana use · summary findings of female review
Intensive discharge planning and case management showed no clear difference in positive hair test for marijuana use compared with prison only (moderate certainty).
1 finding from 1 review